Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

NCT05587439 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT05587439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Lead sponsor
Dana-Farber Cancer Institute
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
November 1, 2027
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disease, genetic predisposition, hereditary diseases, lung cancer